Work

Atim-16. Nivolumab Combined With Radiotherapy With or Without Temozolomide in Patients With Newly Diagnosed Glioblastoma: Results From Phase 1 Safety Cohorts in Checkmate 143

Year: 2016

Type: conference-abstract

Source: Neuro-Oncology

DOI: 10.1093/neuonc/now212.081

Authors: Antonio Omuro, Gordana Vlahovic, Joachim Baehring, Nicholas Arthur Butowski, David A. Reardon, Timothy Cloughesy, Solmaz Sahebjam, Michael Lim, Lewis Strauss, Robert Latek, Ricardo Zwirtes, Prashni Paliwal, Chris Harbison, John Sampson

Institutions: Memorial Sloan Kettering Cancer Center, Duke Medical Center, Yale University, University of California, San Francisco, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, University of California, Los Angeles, Moffitt Cancer Center, Johns Hopkins University, Johns Hopkins Hospital, Bristol-Myers Squibb (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589009574

Cites:

Cited by: 10

Related to: 10